Evidence map›Paper›PMID 27178324›Full record

ArticleJournal of neurovirology2016

HIV-1 Tat causes cognitive deficits and selective loss of parvalbumin, somatostatin, and neuronal nitric oxide synthase expressing hippocampal CA1 interneuron subpopulations.

William D Marks, Jason J Paris, Christina J Schier, Melissa D Denton, Sylvia Fitting, A Rory McQuiston, Pamela E Knapp, Kurt F Hauser

Abstract read
In one paragraph

Article in Journal of neurovirology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Effects of acute ΔBrain research · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

William D MarksDepartment of Pharmacology & Toxicology, Virginia Commonwealth University School of Medicine, Kontos Medical Sciences Building, 1217 East Marshall Street, Richmond, VA, 23298-0613, USA.
Jason J ParisDepartment of Pharmacology & Toxicology, Virginia Commonwealth University School of Medicine, Kontos Medical Sciences Building, 1217 East Marshall Street, Richmond, VA, 23298-0613, USA.
Christina J SchierDepartment of Pharmacology & Toxicology, Virginia Commonwealth University School of Medicine, Kontos Medical Sciences Building, 1217 East Marshall Street, Richmond, VA, 23298-0613, USA.
Melissa D DentonDepartment of Pharmacology & Toxicology, Virginia Commonwealth University School of Medicine, Kontos Medical Sciences Building, 1217 East Marshall Street, Richmond, VA, 23298-0613, USA.
Sylvia FittingDepartment of Psychology & Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-3270, USA.
A Rory McQuistonDepartment of Anatomy & Neurobiology, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298-0709, USA.
Pamela E KnappDepartment of Pharmacology & Toxicology, Virginia Commonwealth University School of Medicine, Kontos Medical Sciences Building, 1217 East Marshall Street, Richmond, VA, 23298-0613, USA.
Kurt F HauserDepartment of Pharmacology & Toxicology, Virginia Commonwealth University School of Medicine, Kontos Medical Sciences Building, 1217 East Marshall Street, Richmond, VA, 23298-0613, USA. kurt.hauser@vcuhealth.org.
Virginia Commonwealth University · USUniversity of North Carolina at Chapel Hill · US

Funding

TRAINING IN THE PHARMACOLOGY OF ABUSED DRUGST32DA007027 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI William L. Dewey · 1985 to 2026
$14.7M
MOR and CCR5 interactive signaling mediates opiate and HIV-driven synaptodendritic injuryR01DA034231 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI HAUSER, KURT F, KNAPP, PAMELA E · 2013 to 2023
$5.4M
Mechanisms of Opiate Drug-HIV-Induced NeurodegenerationR01DA018633 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI HAUSER, KURT F · 2005 to 2021
$4.4M
Glial Progenitors as Targets of HIV/Opiate InteractionsR01DA024461 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI KNAPP, PAMELA E · 2007 to 2018
$3.9M
Regulation of HIV and opiate-directed synaptodendritic injury/death in striatumR01DA033200 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI HAUSER, KURT F · 2013 to 2017
$2.1M
Cholinergic control of neural network functionR01MH094626 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI MCQUISTON, ADAM RORY · 2011 to 2015
$1.9M
Neuron-Glia Mechanisms & Interactions Underlying Opioid Abuse-HIV-1 ComorbidityK02DA027374 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI HAUSER, KURT F · 2009 to 2018
$1.3M
Opiate drug abuse & HIV-induced excitotoxicity in striatal neuronsR00DA033878 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FITTING, SYLVIA · 2015 to 2017
$745k
Opiate abuse and sex steroids influence neuroAIDS pathologyR00DA039791 · NIDA · UNIVERSITY OF MISSISSIPPI · PI PARIS, JASON RICHARD · 2017 to 2019
$734k
Impact of extrahippocampal excitatory inputs on hippocampal CA1 neuron activationR21MH103695 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI MCQUISTON, ADAM RORY · 2014 to 2015
$413k
Opiate abuse and sex steroids influence neuroAIDS pathologyK99DA039791 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI PARIS, JASON RICHARD · 2015 to 2016
$225k
Opiate drug abuse & HIV-induced excitotoxicity in striatal neuronsK99DA033878 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI FITTING, SYLVIA · 2013 to 2014
$220k
NIDA NIH HHS F32 DA039039NIDA NIH HHS K02 DA027374NIDA NIH HHS K99 DA033878NIDA NIH HHS K99 DA039791NIDA NIH HHS R00 DA033878NIDA NIH HHS R00 DA039791NIDA NIH HHS R01 DA018633NIDA NIH HHS R01 DA024461NIDA NIH HHS R01 DA033200NIDA NIH HHS R01 DA034231NIDA NIH HHS T32 DA007027NIMH NIH HHS R01 MH094626NIMH NIH HHS R21 MH103695
6 · The paper itself

Abstract

Memory deficits are characteristic of HIV-associated neurocognitive disorders (HAND) and co-occur with hippocampal pathology. The HIV-1 transactivator of transcription (Tat), a regulatory protein, plays a significant role in these events, but the cellular mechanisms involved are poorly understood. Within the hippocampus, diverse populations of interneurons form complex networks; even subtle disruptions can drastically alter synaptic output, resulting in behavioral dysfunction. We hypothesized that HIV-1 Tat would impair cognitive behavior and injure specific hippocampal interneuron subtypes. Male transgenic mice that inducibly expressed HIV-1 Tat (or non-expressing controls) were assessed for cognitive behavior or had hippocampal CA1 subregions evaluated via interneuron subpopulation markers. Tat exposure decreased spatial memory in a Barnes maze and mnemonic performance in a novel object recognition test. Tat reduced the percentage of neurons expressing neuronal nitric oxide synthase (nNOS) without neuropeptide Y immunoreactivity in the stratum pyramidale and the stratum radiatum, parvalbumin in the stratum pyramidale, and somatostatin in the stratum oriens, which are consistent with reductions in interneuron-specific interneuron type 3 (IS3), bistratified, and oriens-lacunosum-moleculare interneurons, respectively. The findings reveal that an interconnected ensemble of CA1 nNOS-expressing interneurons, the IS3 cells, as well as subpopulations of parvalbumin- and somatostatin-expressing interneurons are preferentially vulnerable to HIV-1 Tat. Importantly, the susceptible interneurons form a microcircuit thought to be involved in feedback inhibition of CA1 pyramidal cells and gating of CA1 pyramidal cell inputs. The identification of vulnerable CA1 hippocampal interneurons may provide novel insight into the basic mechanisms underlying key functional and neurobehavioral deficits associated with HAND.

Indexed as

AnimalsCA1 Region, HippocampalCognitionCognitive DysfunctionGene Expression RegulationInterneuronsMaleMaze LearningMiceMice, TransgenicNeuropeptide YNitric Oxide Synthase Type IParvalbuminsSignal TransductionSomatostatintat Gene Products, Human Immunodeficiency VirusNeuropeptide YNitric Oxide Synthase Type INos1 protein, mouseParvalbuminsSomatostatintat Gene Products, Human Immunodeficiency VirusBistratified cellInterneuron specific interneuron type 3 (IS3)NeuroAIDSNeurodegenerationOriens-lacunosum-moleculare cell (O-LM)Spatial memory

Identifiers

PMID27178324
PMCPMC5107352
OpenAlexW2351778937

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.